Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL! Look again!
I see down another 3.4% by the end of the trading session. The string of losses continues! Down 85.6% following the Reverse Split, which happened less than 5 months ago on December 16, 2020!
It appears adept traders and investors understand what happens to Company's that are substantially over-valued and highly dilutive! 13,000,000 million shares were outstanding on January 1, 2021, but the outstanding count has blown up by 40-fold to 530,000,000 in just 4 months!
...AND DOWN 4%!
Let's take a peak at SPRV's reality!!!
Per the Annual Financial Report, which was re-released on April 18, 2021:
The above relates to the first and so far only Medical Office Building acquired by SPRV. Based on the actual numbers, the building is not particularly special, i.e. it appears to be a DUMP! Here's the reality! The lauded MOB was purchased with 10,000,000 SPRV shares, which, based on the current valuation, is less than $200,000. And the $200,000 MOB is SPRV's only known asset!
Who was the mystery person who got the 5 million preferred Series A shares????
SPRV's current Market Cap of nearly $10 million is so high it defies rational perspective! And the $10 million is only a tiny portion of the 517 million shares that have been distributed since the first of the year! Where did the other 507 million shares go? 200 million shares were used to pay for "Professional Services". Who was the "Professional"??? 100,000 were used to pay debts and this will be a recurring theme!
I suggest REALLY looking again!
FACT!!! THE SPRV SHARE PRICE IS DOWN OVER 80%, SINCE THE DECEMBER 16, 2020 1-FOR-1000 REVERSE SPLIT!
SPRV is a pile of garbage!
Not only is the share price DOWN 80% in less than 5 months, but the OUTSTANDING SHARES have ballooned from 13 million to 530 million, an increase of 517 million shares or a 40-fold increase, which clearly serves to bludgeon real investors with devastating dilution!
NO IT DOESN'T! The ASK has already backed down and the last trade was a retrench!
NOT A CHANCE!!! SPRV is not even in the universe of the minimum standards for being qualified to join the NASDAQ!
I suspicion CEO Keith Berman, who we now know fraudulently posted here on IHub using the alias "Plutoniumimplosion", will not consider the ceiling of an 8' X 10' Federal prison to be the touted "blue skies"!
LOL!!! Stock trading 101????
The so-called "Stock trading 101" theory has NEVER worked here at KGET! There was a small amount of movement in the share price back in early 2014, but the share price has been in the trips ever since Bobo "The Hobo" Linton took control in late 2013! With nearly 14 BILLION shares outstanding, getting any significant positive share price movement is beyond fantasyland!
Yep! Just an "opinion"! The FACT is the annual Attorney Letter doesn't mean jack for the share price! For OTC companies choosing to report via the Alternative Reporting Standard the annual Attorney Letter is an absolute OTC Markets' requirement. The reporting company has no choice!
Since DECN has opted to use the Alternative Reporting Standard, it has posted an annual Attorney Letter on nearly the same date every year. Here are the last 5 Attorney Letter dates and all were in conjunction with DECN's annual financial report:
April 28, 2021
March 30, 2020
April 23, 2019
March 31, 2018
March 30, 2017
LOL! All five Attorney Letters are nearly identical and basically say NOTHING!
Per the recently posted Annual Financial Report, DECN does not even have the financial resources needed to produce and ship $47 million worth of anything! Funniest thing! Raw material vendors and contract manufacturers, such as The Bio, demand payment for their products. Unlike Berman's BS, real companies don't wait around for 180 days waiting to get paid!
And many lottery players are going to have difficulty selling these shares, when brokers like TD Ameritrade and Schwab completely BAN purchases of Caveat Emptor issues effective May 25, 2021. Who's going to buy the KGET shares the lottery players will be hoping to sell? Not the clients of TD Ameritrade and Schwab. Fidelity and E*Trade have already instituted a similar prohibition. Many others will follow. Plus the SEC will commence whacking the trading of shareholder information-delinquent OTC equities come June 30, 2021. Come mid-2021, the typical pump & dumps will take a seriously big hit!
This may come as a revelation, but the so-called "Pedo" or more formally, Bobo "The Hobo" Linton, holds voting controlling of KGET! Nobody can force him out!
Not even the Village Idiot would be interested in buying Bobo out, due to the obscene share structure, the mountain of debt, and the FACT the seriously delinquent KGET shell is designated Caveat Emptor and has been relegated to the Gray Market, as a function of blatantly fraudulent product promotions!
LOL! Here's a revelation! A Purchase Order means NOTHING, when the provider cannot deliver the goods. DECN can deliver NOTHING, meaning the touted Purchase Order is NOT worth the paper it is printed on!
FYI...a vendor/distributor has no legal obligation to honor a Purchase Order, which basically means the cited PR is just one more DECN attempt to fraudulently manipulate its share price!
Most often those receiving large Purchase Orders announce the "news", as it can be construed a Material Event. Who gives a damn if the buyer announces a large Purchase Order??? It means NOTHING!
Too bad Berman is "gagged", meaning he had to have another fraudster do his bidding!
How about some EVIDENCE supporting the claimed trend??!! Attorney Letters have been posted following the issuance of annual reports for decades, but they have no direct impact on removing the Caveat Emptor designation!
There are multiple conditions, not just delinquent financial reports, which cause OTC Markets Group to assign the Caveat Emptor designation. FYI, missing annual Attorney Letters is not one of them!
DONE! The Transfer Agent verified outstanding count, as of April 30, 2021, was 13.877 BILLION shares, with virtually all of the outstanding shares being Unrestricted.
https://www.otcmarkets.com/stock/KGET/security
LOL! It's been the SAME awesome chart since Bobo "The Hobo" Linton became the CEO in 2013! KGET was a heavily "pumped" share selling scam in 2013 and remains a scam today! Of course there is one significant difference between 2013 and 2021. KGET continues to have NO BUSINESS OPERATIONS, but it was SUSPENDED by the SEC in 2020, leading to being designated Caveat Emptor and trading via the OTC Gray Market.
The above relates to two different unconnected issues!
Filing a current quarterly report does not automatically make the company "Pink Current". OTC Markets makes the decision to remove the Caveat Emptor designation, with a current report not being the sole qualification. Keep in mind, DECN has posted quarterly reports, since being suspended by the SEC, but the Caveat Emptor designation remains. The Attorney Letter has no bearing on the CE situation! It is simply a normal procedure for those choosing to file an annual financial report, using the Alternative Reporting Standard.
The scramble caused by the SEC is specifically related to the new SEC disclosure amendment that was delivered last September. It has nothing to do with being Caveat Emptor. The new SEC Disclosure Rule is specific to ANY OTC company, Pink or otherwise, which is deemed delinquent in reporting Material Events and quarterly financial information. A current financial report does not remove the CE designation, but it does remove the SEC's disclosure scrutiny.
The SPRV share price has PLUMMETED 84.7%, following the December 2020 1-for-1000 Reverse Split! It appears the lottery players, having been crushed by the RS, are dreaming about mitigating the brutal losses of the last four months.
Thanks! So the two DECN Balance Sheet asset lines, Patent Licensing and Intellectual Property, are most likely further evidence CEO Keith Berman is driven by a focus on "fantasies"! LOL!
Given the facts, it seems a bit "overzealous" for DECN to be carrying Patent Licenses, Net Value of $2,490,825 on the Balance Sheet. Interestingly, the Net Value did not "depreciate" year-over-year. I was suffering under the allusion the Shasta settlement included patent rights, but no Shasta patents appear to be included on the DECN Balance Sheet. The above line item first appeared on the Balance Sheet for the period-ended 9/30/2018, long after Shasta was settled. Unfortunately there have been no auditors to review the patent valuation and validity of the claim.
Was a Shasta patent(s) assigned to PharmaTech Solutions, prior to Berman negotiating with himself to arrange the DECN buyout of PharmaTech Solutions? What were the terms and conditions of the PharmaTech acquisition? How much did the DECN shareholders pay Berman for PharmaTech?
And then there is the DECN IP asset, which is valued at $733,830, but is without any explanation/footnote to clarify what this might include. There was no IP valued on the Balance prior to Q3 2018. I suspect it is related to the The Bio arrangement.
The above line items first appeared on the Balance Sheet, during the period-ended 9/30/2018, and have increased since. Unfortunately there have been no auditors to check on the validity of the claims. And no transparency from Berman to tell the DECN investors where the valuations came from.
The shareholder class-action lawsuits might serve as a grand forum for discussing the valuations. Very simply, if no patents, what is being valued?
A few months ago I raised the flag on CEO Keith Berman possibly being the designated "owner" of the glucose test kit patent(s), then negotiating an arrangement with himself to license the patents to DECN and personally pocketing a monthly license fee.
It would be an egregrious failure of Berman's fiduciary obligation to the DECN shareholders to use DECN funds in pursuing the patent litigation against other companies, such as Shasta, then assigning the obtained IP to himself. Berman's legal rebuttal, as he attempts to mitigate the pre-trial release restrictions, would seem to suggest Berman could well be compensating himself via patent license fees. Per the recently filed court document:
Even the Village Idiot knows CEO Keith Berman, DECN's only Director and Officer, is pulling a good chunk of cash out of DECN. Based on the DOJ investigation, we now know about Berman's live chat fetish, which led to over $300,000 being absconded from the DECN investors, but what about direct personal payments for the patent licenses and consulting services?
IMO, there is no doubt DECN is Berman's personal piggy bank!
Great analogy!
The crap about "NEW MANAGEMENT" is a stitch! ATMH is a one man show!!!
Massimo Travagli alone is charged with running the operation! PERIOD! Everyone else is Travagli's pawn. Massimo Travagli has been around since 2019. He personally approved and oversaw the shareholder crushing August 2020 1-for-200 Reverse Split!
https://www.otcmarkets.com/stock/ATMH/news/Toron-Inc-Notice-of-Material-Event-and-Company-Update?id=259547
Massimo Travagli holds the equivalent of 1.25 BILLION shareholder votes. Anyone working for ATMH, including CEO Massimo Meneghello, serves at the behest of Travagli.
EFFECTIVELY, TRAVAGLI BY HIMSELF IS THE HIGHLY TOUTED "CURRENT MANAGEMENT"!
No "DEAL" involved!
The ATMH website did not equivocate! The highly touted "CURRENT MANAGEMENT", which isn't really "new", posted a pile of BULLSHIT, when it was promoting a completely FALSE FY 2021 Revenue forecast!
Rest very assured such a claim is blatant SECURITIES FRAUD!
As was PROVEN earlier today, the CURRENT MANAGEMENT was the group touting $42 million in Revenue for FY 2021! The FY 2021 Annual Financial Report, which is required to be posted within 10 days, will provide irrefutable evidence CURRENT MANAGEMENT'S $42 million Revenue claim was complete unadulterated BULLSHIT!
Funniest thing! After CURRENT MANAGEMENT concluded they were likely to get whacked for SECURITIES FRAUD, the $42 million revenue BULLSHIT was abruptly removed from the ATMH website!
How quickly we ignore the FACTS!!! I seem to recall the share price was at .30, following the Reverse Split less than a year ago! The ATMH stock is down 40% in the last 9 months!
Can't wait until the FY 2021 Annual Financial Report, which is required to be posted to OTC Markets in the next 10 days, is claimed to be a "TYPO" or a "PHOTOSHOP JOB"!
LOL!!!!
I suggest a review of the Principles of Corporate Fiscal Accounting 101!
An accounting FISCAL YEAR is not the same as a CALENDAR YEAR.
Per Investopedia:
The ATMH FISCAL YEAR (FY) 2021 ended on January 31, 2021!
FY 2021 WAS OVER NEARLY 3 MONTHS AGO, which is exactly why the FY 2021 Annual Financial Report will be so mind-numbing and revealing for the ATMH investors. The Annual Report is due to be posted to OTC Markets by the end of April 2021, i.e. 90 days following the end of the 2021 FISCAL YEAR.
ATMH is now working on FISCAL YEAR 2022!
LOL! Happy to be of service! The PROOF has been posted numerous times by the ATMH supporters. One would assume the same PROOF would not have to be posted over and over again, but here it is!
Remember the Company's FRAUDULENT projection of $42 million in FY2021 Revenue???
D-day is fast approaching. The FY2021 Annual Financial Report is due to be posted to OTC Markets within the next 10 days. ATMH will be lucky to show Revenues of more than ONE DOLLAR, let alone the BS Company's claim of $42 million in Revenue!
ATMH's credibility sucks!
Nothing related to ATMH has been disclosed or posted to OTC Markets, since January 4, 2021. Yeah...more than four months have passed and nothing from ATMH's crack executive team. Maybe the Chairman is having trouble with his role as Company "translator"! What happened to the Bitcoin gift card that was supposed to be introduced in the U.S. in "March of this year"?
What a joke! Check out the website. A buyer can buy an Amazon gift card in the U.S. for 25 USD and can only use the Amazon gift card in the U.S. Where's the crptocurrency functionality????
The old is forever new!!! I had never fully reviewed the civil class-action Complaint against AccessHealthNet. The following charge sounds vaguely familiar!
SOUNDS IDENTICAL TO THE CURRENT VERSION OF DECN!
The first large Bad Debt write-off occurred in early 2020. The Q1 2020 write-off was $450,000. It appears another $370,000 was written off in Q4 2020. The total Bad Debt for all of 2019 was $175,000 and there was no Bad Debt write-off for 2018. The three year's total Bad Debt writedown was $995,000, with $820,000 (80+%) of this done in fiscal year 2020.
Interestingly, the Q1 2020 $450,000 writeoff came after I started chatising Berman for taking minimal writedowns, when the DSO is beyond 180 days. A DSO of 180+ days is an out-of-control Accounts Receivable turnover metric. No wonder Berman needs a massive inventory line-of-credit to conduct the DECN glucose test kit business. If the Accounts Payable average is 180 days, which approximates the DECN situation, there is more than a good chance a significant portion of the debt will never be collected. Even with the write-offs, the Accounts Receivable balance remains nearly 50% of the 2020 Revenue total. No wonder Berman has problems dealing with accountants! The business sucks and DECN's Revenue was down more than $400,000 (-20%) year-over-year, 2020 vs. 2019.
Based on the quarterly report, it appears the distributor(s) are the middleman between DECN and the aforementioned etailers. The distributor is the DECN customer. If the etailers don't buy the product, the distributor remains on the hook to pay the DECN invoice.
DECN does not have the logistical wherewithal to handle the above distribution structure. Shipping to only x-many distributors makes far more sense.
In my mind the questions become...
"What happens to all of the distributors' unsold DECN glucose kit inventory?
How many diabetics are actually buying and using the products?"
Did you note DECN's ultimate Bad Debt expense for 2020 was $820,000 or roughly 40% of DECN's annual glucose test kit revenue?
What a business! Take an order (phony order?), ship the product, send an invoice, book the revenue, then write-off it off a few short months later! This sort of crap is commonly referenced as "cooking the books"!
Just a guess! Due to the lack of any D&O insurance, Pluto is scrambling like hell to hide his personal assets!
Here's another interesting tidbit from Berman's magical pen!
The product was purportedly ready on go by the end of September 2020 and a touted distribution agreement was consummated prior to the 9/26 release date. How can this be? DECN reported no 4th quarter revenue from even one GenViro kit sale!
Here's how revenue recognition works! It's not rocket science. A customer, in this case a distributor, issues a purchase order, the product is shipped, the seller provides an invoice, and the seller books the revenue. WHERE'S THE REVENUE???? The product was supposedly ready to go on September 26, 2020, but no revenue was produced even 90+ days after the international GenViro product release.
Does anyone else find the following statement, which was included in the recently posted 2020 Annual Report, a bit humorous?
Say what????
I could be mistaken, but it doesn't seem the following, which was included in the recently posted DECN Annual Report, was ever included as a part of any previous quarterly reports. It should have appeared in the Q1 2020 Quarterly Report and each subsequent Quarterly Report!
Methinks Pluto may be a bit nervous, as the Feds are combing the DECN books!
The post is dead nuts on! THANKS!
Here's what OTC Markets has to say about the Caveat Emptor designation:
HSTH has not filed a financial report in nearly 9 years, but at the time of its last report, the Company was designated an SEC reporting entity, not subject to any OTC Markets' conditions. This is just a guess, but it appears the answer to your question revolves around never being subject to OTC Markets' terms and conditions. The grey market symbol is different than any other I've seen.
Honestly, since HSTH is listed as an SEC reporting entity, it is shocking the stock has never been de-listed for delinquent financial reporting. I will send a note to the SEC to bring its attention to the situation.